Skip to content

Insider · CIK 0001761826

Kathryn Jean Boor

director

Files at IFF (INTERNATIONAL FLAVORS & FRAGRANCES INC), SRPT (Sarepta Therapeutics, Inc.). First filing Dec 6, 2024, latest Dec 6, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $205k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SRPT: Sarepta Therapeutics, Inc.

SRPTOct 9, 2026 · close 17.85

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
SRPTsell 2
Sarepta Therapeutics, Inc.
$205k
1,636 shares
-22%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 1, 2025IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
AGrant or award
Restricted Stock Unitsderivative
+2,569$0.00$02,569May 5, 2025
Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
AGrant or award
Common Stock
+2,383--8,263Mar 11, 2025
Mar 10, 2025SRPT
Sarepta Therapeutics, Inc.
AGrant or award
Stock Options (right to buy)derivative
+4,792$0.00$04,792Mar 11, 2025
Dec 5, 2024SRPT
Sarepta Therapeutics, Inc.
SOpen-market sale
Common Stock
-1,636$125.55$205k5,880Dec 6, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kathryn Jean Boor: insider trades and track record | InsiderTell